After graduating as an engineer from the National School of Chemistry in Paris, Larry ABENSUR went on to obtain an MBA from INSEAD. For 9 years, he held various marketing positions in the pharmaceutical industry, first as a Product Manager for biosynthetic human insulin with Eli Lilly, then as Marketing Manager at Upjohn in France. He subsequently was Managing Director at PBS Orgenics, an actor of the in-vitro diagnostics market, for 6 years, until the company’s merger with Self Care (INVERNESS) and its introduction on the Nasdaq. In 1993 and 1994, Mr Abensur successively co-founded the companies All Diag and Dectra Pharm. In 2005, Larry Abensur participated in the creation of Biosynex, which he co-managed until October 2010. In June 2015, Larry ABENSUR initiated the creation of the Biosynex group, medtech leader in rapid diagnostic test RDTs). He holds the position of CEO of the Biosynex group.


Thierry PAPER (Deputy Chairman)

Pharmacien biologiste / MBA Ecole des Ponts

After completing a second cycle in pharmaceutical studies at the University of Paris V, Thierry PAPER completed an MBA at the Ecole des Ponts. He also graduated in medical biology from the University of Paris V. Intern in Pharmacy until May 1990, Thierry PAPER first joined an Israeli company, Orgenics, where he was project manager then marketing manager. Between 1993 and 1997, he was in charge of the development of the French company Matara. Between 1997 and 2005 he was deputy director of the medical laboratory J-P Accary. He also has been managing since 1997 Axodev, a business development services company in the in-vitro diagnostics industry. In 2005, Thierry PAPER participated in the creation of Biosynex, and became its managing and operational director. In June 2015, he became Deputy Chairman of the Biosynex group.


Thomas LAMY (Deputy Chairman)

PhD Engineer / EMBA HEC

After graduating as an agricultural engineer, Thomas LAMY also obtained a PhD in Engineering from the Polytechnic Institute of Lorraine in 1986. After 4 successful years in sales and marketing at Baker Instrument (Johnson & Johnson), he joined the sales management team at PSB Orgenics (IVD actor) until its merger with Self Care (INVERNESS). Thomas LAMY co-founded the All Diag and Dectra Pharm companies with Larry ABENSUR and was the Managing Director at All Diag from 1993 to 2015. In parallel in 2005, Thomas LAMY participated in the creation of Biosynex and actively contributed to the development of the company’s activities. In June 2015, Thomas LAMY became Deputy Chairman of the Biosynex group.